ArticleActa pharmacologica Sinica2017

The novel α-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells.

Dan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.